Fig. 8From: Advancements in nanoparticle-based treatment approaches for skin cancer therapyIllustration of cRGD-installed reduction-responsive crosslinked nanotherapeutics from star PLGA-lipoic acid conjugate (cRGD-sPLGA XNPs) for enhanced DOX delivery to B16F10 melanoma bearing mice in vivo, reproduced with permission from [277], copyright 2019, American Chemical SocietyBack to article page